We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Potential costs and effects of the National Service Framework for Coronary Heart Disease in the UK.
- Authors
Vella, V.; Vella, Venanzio
- Abstract
<bold>Objective: </bold>To estimate the costs and effect of implementing the National Service Framework for Coronary Heart Disease (CHD) in the UK.<bold>Design: </bold>Decision trees were built on the results from randomised controlled trials on improving coronary revascularisation. All costs were presented in UK pounds (1997 values).<bold>Patients: </bold>Each year 6600 new patients with CHD are expected to require revascularisation in the UK.<bold>Interventions: </bold>The new patients would be equally divided into those undergoing coronary artery bypass grafting (CABG) and those undergoing a percutaneous coronary intervention (PCI) i.e., percutaneous transluminal angioplasty (PCTA). PTCA could be administered with or without abciximab (a glycoprotein IIb/IIIa receptor antagonist), stent, or stent plus abciximab (stent+).<bold>Results: </bold>CABG/stent alone has an incremental cost of more than 115,489 pounds per additional quality-adjusted life-year (QALY) gained compared with CABG/ PTCA+. This high incremental cost is not attractive because if CABG/ stent would be added to abciximab (CABG/stent+) its incremental cost-effectiveness ratio would be 2529 pounds per extra QALY compared with CABG/stent. Therefore, the debate should not be limited to the issue of stents but it should focus on the need for administering abciximab in addition to stent. The 5-year direct costs of implementing such a strategy in the UK is expected to be 50.6 million pounds (1997 values).<bold>Conclusions: </bold>Abciximab and probably any glycoprotein IIb/IIIa receptor antagonists should be added to any PCI, especially if stents are used.
- Subjects
UNITED Kingdom; NATIONAL service; CORONARY disease; MEDICAL care costs
- Publication
PharmacoEconomics, 2003, Vol 21, Issue 1, p49
- ISSN
1170-7690
- Publication type
journal article
- DOI
10.2165/00019053-200321010-00004